The Venture Codex Logo

The Venture Codex

Loyal

756 West Peachtree Street Northwest, Suite 725, Atlanta, Georgia, 30308, United States

Overview

Loyal’s AI-powered consumer engagement platform helps health systems consolidate disparate technology stacks, streamline patient navigation, and drive care utilization across the patient journey. The platform is used by a customer base of 38 health systems and the company reports a track record of continued revenue growth. Loyal says its solution makes it easier for patients to connect with care and drives loyalty to health providers. The recent financing is intended to fund expansion of the customer base, further product development, bolster customer success, and accelerate growth. As part of its growth plans the company announced executive and board changes to support scaling efforts. Loyal is headquartered in Atlanta. Loyal offers a proprietary, end-to-end digital and AI-powered consumer experience platform designed to streamline the patient journey — from provider selection and scheduling to closing the feedback loop. The company focuses on improving care utilization and patient engagement among hospitals and health systems. Loyal's platform is used by more than 30 hospitals and health systems, including Northwestern Medicine and UCLA Health, and the company has reported significant commercial growth. The announced funds will be used to enhance and expand the existing platform and to secure talent and resources to realize a personalized patient experience across all aspects of care. Loyal positions itself as a healthcare consumer experience company dedicated to making access to care easier and increasing patient loyalty. The company highlights its role in helping health systems remain engaged with patients during a tumultuous period for hospitals.

Total raised
$46M
Funding rounds
2
Latest round
Series B
Latest activity
Jul 2024

Industries

  • Artificial Intelligence (AI)
  • Health Care
  • Information Technology
  • Machine Learning
  • Medical
Visit website

Recent funding

  1. Series B

    Jul 2024

    $34M

  2. Series A

    Oct 2020

    $13M

Team